Solid Biosciences

SLDB · NASDAQ

$6.40+$0.48 (+8.11%)TodayMarket closed ·
Prev close $5.92

Who owns SLDB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 69.9% of SLDB’s shares.

  • RA Capital Management, LP12.2%
  • Perceptive Advisors LLC12.1%
  • Bain Capital Life Sciences Investors, LLC10.0%
  • Invus Public Equities Advisors, LLC7.8%
  • Next 6 largest institutions27.8%
  • All other shareholders30.1%
Top institutional holders of SLDB
HolderShares% of shares
RA Capital Management, LP12.04M12.23%
Perceptive Advisors LLC11.91M12.09%
Bain Capital Life Sciences Investors, LLC9.81M9.96%
Invus Public Equities Advisors, LLC7.69M7.81%
BlackRock Institutional Trust Company, N.A.6.17M6.26%
Fidelity Management & Research Company LLC4.69M4.77%
Armistice Capital LLC4.28M4.35%
State Street Investment Management (US)4.18M4.24%
Janus Henderson Investors4.04M4.11%
Vanguard Capital Management, LLC4.01M4.07%

Largest mutual fund holders

Top mutual fund holders of SLDB
HolderShares% of shares
Vanguard Total Stock Market Index Fund3.15M3.20%
State Street SPDR S&P Biotech ETF2.73M2.77%
Franklin Templeton Investment Funds -Biotechnology Discovery2.62M2.66%
Fidelity Select Biotechnology Portfolio2.61M2.65%
iShares Russell 2000 ETF2.04M2.08%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of SLDB in the last 6 months.

Latest SLDB insider transactions
InsiderTypeSharesValue
SMITH IAN FOption exercise3.44K—
SMITH IAN FOption exercise3.44K—
SMITH IAN FOption exercise3.44K—
SMITH IAN FOption exercise3.44K—
Ganot IlanAward77.50K—
Keresty GeorgiaAward77.50K—
Kahn ClareAward77.50K—
Sullivan Lynne MarieAward77.50K—
Stone Adam LeoAward77.50K—
Freed Martin IAward77.50K—

Short interest

Settled Sep 30, 2026

Shares short
12.73M
Days to cover
7.69
% of shares outstanding
12.93%
Average daily volume
1.66M
Change since last report
−25.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.